Background: Some hemodialysis patients develop hemodialysis access-induced distal ischemia due to insufficient loco-regional perfusion pressure and consequent poor arterial flow. We hypothesized that patients with severe hemodialysis access-induced distal ischemia had worse survival compared with patients with mild or no hemodialysis access-induced distal ischemia. Methods: This single-center retrospective observational cohort study included three groups of prevalent hemodialysis patients with an upper extremity vascular access between 2006 and 2018. Symptomatic patients had signs and symptoms of hemodialysis access-induced distal ischemia and low digital brachial indices (<60%) and were divided into a mild (Grade I–IIa) and a severe hemodialysis access-induced distal ischemia (IIb–IV) group. The control group consisted of hemodialysis patients without signs of hemodialysis access-induced distal ischemia with digital brachial indices ≥60%. Factors potentially related to 4-year survival were analyzed. Results: Mild hemodialysis access-induced distal ischemia-patients displayed higher digital brachial indices ( n = 23, 41%, ±3) compared with severe hemodialysis access-induced distal ischemia-patients ( n = 28, 24%, ±4), whereas controls had the highest values ( n = 48, 80%, ±2; p < .001). A total of 44 patients (44%) died during follow-up. Digital brachial index (hazards ratio 0.989 [0.979–1.000] p = .046) was related to overall mortality following correction for presence of arterial occlusive disease (hazards ratio 2.28 [1.22–4.29], diabetes (hazards ratio 2.00 [1.07–3.72], and increasing age (hazards ratio 1.03 [1.01–1.06] as was digital pressure (hazards ratio 0.990 [0.983–0.998], p = .011). Overall survival was similar in mild hemodialysis access-induced distal ischemia and controls (2-year, 79% ±5; 4-year, 57% ±6, p = .818). In contrast, 4-year survival was >20% lower in patients with severe hemodialysis access-induced distal ischemia (2-year 62%± 10; 4-year 34% ± 10; p = .026). Conclusion: Presence of severe hemodialysis access-induced distal ischemia may be associated with poorer survival in hemodialysis patients. Lower digital brachial index values are associated with higher overall mortality, even following correction for other known risk factors.

Background Aim of the study was to determine associations between characteristics of arteriovenous access (AVA) access flow volume (Qa, mL/min) and four year freedom from cardiovascular mortality (4yr-CVM) in hemodialysis (HD) patients. Methods HD patients who received a primary AVA between January 2010 and December 2017 in one center were analyzed. Initial Qa was defined as the first Qa value obtained in a well-functioning AVA by a two-needle dilution technique. Actual Qa was defined as access flow at a random point of time. Changes in actual Qa were expressed per 3-month periods. CVM was assessed according to the ERA-EDTA classification. The optimal cut-off point for initial Qa was identified by a receiver operating characteristic curve. A joint modelling statistical technique determined longitudinal associations between Qa characteristics and 4yr-CVM. Results A total of 5208 Qa measurements (165 patients, male n = 103; age 70±12 years, autologous AVA n = 146, graft n = 19) were analyzed. During follow-up (Dec 2010-Jan 2018, median 36 months), 79 patients (48%) died. An initial Qa &lt; 900 mL/min was associated with an increased 4y-CVM risk (HR: 4.05; 95% CI [1.94-8.43], P&lt;0.001). After 4 years, freedom from CVM was 34% lower in patients with a Qa &lt; 900 mL/min (53 ±7% vs. Qa ≥ 900 mL/min: 87 ±4%, P &lt;0.001). An association between increases in actual Qa over 3-month periods and mortality was found (HR: 4.48 per 100mL/min, 95% CI [1.44-13.97], P =0.010) indicating that patients demonstrating increasing Qa were more likely to die. By contrast, actual Qa per se was not related to survival. Conclusions Studying novel arteriovenous access Qa characteristics may contribute to understanding excess CVM in HD patients.

Patients in all stages of chronic kidney disease (CKD) are considered in the "high-risk group" for development of cardiovascular disease (CVD). The study was undertaken in 60 adult patients of chronic renal failure. The patients were divided into three groups: Group I had subjects with CKD (stages 1 and 2); Group II had subjects with CKD (stages 3 and 4) on conservative therapy for 3 months; and Group III had subjects with CKD (stage 5) on regular hemodialysis for at least 3-4 weeks. Carotid sonography was done in all patients at the time of inclusion in the study. The patients in all the groups were then followed for 6 months and the relevant investigations were carried out, initially at the time of presentation, and then at third-and sixth-month interval. The patients were monitored for various renal parameters along with serum lipoprotein-A [Lp (A)]. The value of carotid intima media thickness (CA-IMT) was increased in group II and III as compared to group I. The calcification of carotids was higher in patients of group III. The maximum number of patients having plaques and stenosis in the carotids were seen in group III (50%), followed by group II (20%). Patients in group III had 5-10 times higher levels of Lp (A) as compared to patients in group I. The comparison of Lp (A) levels between group I and group II was also highly statistically significant.

No abstract

Introduction An abnormal ankle‐brachial index indicating presence of peripheral arterial disease (PAD) is known to predict mortality in end‐stage renal disease (ESRD). Hand ischemia, reflected by low finger pressures, is also a factor associated with increased mortality in patients undergoing hemodialysis (HD). The Aim of the present study is to determine whether an abnormal digital brachial index in ESRD patients prior to HD access surgery is related to lower survival rates. Methods A digital brachial index (DBI, systolic finger pressure/systolic brachial arterial pressure) was obtained using digital plethysmography in ESRD patients before construction of a primary HD access between January 2009 and December 2018 in a single center. Patients were grouped based on categories of DBI (low <80%, normal 80–99%, high ≥100%). Overall and cardiovascular mortality were assessed with the ERA‐EDTA classification system (ERA‐EDTA codes 11, 14‐16, 18, and 22‐26, 29). Factors potentially influencing survival rates were analyzed using standard statistics. Findings Follow‐up was available in 199 patients (female n = 80; age 70 years ±12; follow‐up index 99% ±1). Overall, 2 and 4 years survival were similar among DBI groups Moreover, 2 and 4 years freedom from cardiovascular death were also not different (low DBI 80% ±8 and 58% ±11; normal DBI 86% ±4 and 75% ±6; high DBI 74% ±6 and 61% ±7). Following correction for age, diabetes mellitus, cardiovascular disease and smoking, a high DBI conferred a significantly increased risk of cardiovascular mortality (HR 2.09 [1.06–4.13], P = 0.03) and a trend toward higher overall mortality (HR 1.69 [0.98–2.93], P = 0.06). Discussion ESRD patients with an abnormally elevated DBI before HD access creation have an increased risk of cardiovascular mortality in the first four postoperative years.